While many companies combine the roles of the CEO and Chairman of the Board, Celgene ( CELG) has found success in keeping those duties separate-so long as the company’s mission keeps on a singular course, according to its Executive Chairman Bob Hugin. He also discussed the increased role and impact of passive investors, active investors and management, and how long term solutions to the issues raised by those groups can affect shareholder value.
